Bonnie Overton, Group Associate Creative Director, MicroMass Communications
In this episode, we talk about how behavioral science is addressing some of pharma’s biggest challenges.
Dr. Janine Collins, Executive Director, Safety, Epidemiology, Registries and Risk Management
Eli Phillips Jr, PharmD, JD, Vice President, Insights & Engagement and Regulatory Sciences, Cardinal Health
Andrew Schirmer, CEO, Ogilvy Health
Bonnie Overton, Group Associate Creative Director, MicroMass Communications
Anita Nelsen, Vice President, Translational Medicine, Parexel
Angela Qu, Senior Director, Biomarkers & Genomic Medicine, Parexel
